Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Apr 29, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- AHRQ Notice of Extension of PA-21-202
Agency for Healthcare Research and Quality
- Publication of the Revised NIH Grants Policy Statement (Rev. April 2021) for Fiscal Year 2021
National Institutes of Health
- Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel
National Institutes of Health
Agency for Healthcare Research and Quality
Food and Drug Administration
General Notices
- Notice of Pre-Application Technical Assistance Webinar for RFA-AT-21-006, "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)"
National Center for Complementary and Integrative Health
National Institute of Neurological Disorders and Stroke
- Pre-Application Webinar for the Clinical Proteomic Tumor Analysis Consortium (CPTAC): RFA-CA-21-023 (U24), RFA-CA-21-024 (U24), and RFA-CA-21-025 (U01)
National Cancer Institute
- Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic
National Institute of Dental and Craniofacial Research
- NIDCR Policy on Applications for Investigator-Initiated Clinical Trials
National Institute of Dental and Craniofacial Research
- Continuation of Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
National Institute of General Medical Sciences
- Notice of Pre-Application Technical Assistance Webinar for RFA-MD-21-004, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
- Notice of Intent to Reissue PAR-18-845 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) and PAR-18-846 (R21 - Clinical Trial Not Allowed) as a Notice of Special Interest (NOSI)
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
- Notice of Intent to Reissue PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01- Clinical Trial Optional) and PAR-18-848 (R21 - Clinical Trial Optional) as a Notice of Special Interest (NOSI)
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
- Notice of Pre-Application Webinar for Phase II of the RADxSM-UP Initiative
National Institutes of Health
- Request for Information (RFI): Seeking Stakeholder Input on Enhancing Cancer Health Disparities Research
National Cancer Institute
- Request for information (RFI) on enhancing the science for the Environmental influences on Child Health Outcomes (ECHO) program
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Notice of Changes to Funding Opportunities
- Notice of NIAMS Participation in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Change to NOT-OD-21-087, Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
National Cancer Institute
- Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
National Institute on Drug Abuse
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
- Notice of Change to PAR-20-214, "Research to Improve Native American Health (R21 Clinical Trials Optional)"
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
- Notice of Requirement for Submission of Current and Pending Support Information for the PD(s)/PI(s) of PAR-20-115 Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30)"
National Institute of General Medical Sciences
- Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-313 Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)
National Institute of General Medical Sciences
- Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-312 Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)
National Institute of General Medical Sciences
- Notice of Additional Information for PAR-20-101, Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Early Termination of PAR-21-162, Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
- Notice of Early Termination of PAR-21-152, NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed).
National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01)
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24)
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24)
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions (TBEL) (U24 Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)
National Cancer Institute
Notices of Special Interest
- Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest (NOSI): Administrative Supplements to Stimulate and Strengthen Global Cancer Survivorship Research
National Cancer Institute
- Notice of Special Interest (NOSI): Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees
National Institute of Neurological Disorders and Stroke
- Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain (Admin Supp Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
Funding Opportunities
- NICHD Small Research Grant Program (R03 Clinical Trial Required)
- NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
- NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
- Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed)
- Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
- Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
- Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)
National Institute of Mental Health
- NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu.